thx Historian for reminding me of NASDAQ's resurgence of its downtrend. I am not going to "bemoan" it but the fact is many BIOS are oversold and I have way too much invested accordingly. Please keep in mind there are many here who understand when options are being sold or shorts covering or manipulation far better than I. If you are OK with Insmed being in the mid-$14s great. I am not. as someone posted earlier, we should be nearing $20. Just doesn't compute with me how this continues. Anyway, I bought at $13.35 and $14.01 the past few days.
Insmed price target raised to $51 from $45 at Piper Jaffray
Piper Jaffray increased its price target on Insmed after meeting with the company's management, as the firm thinks the company's NTM will be approved. The firm keeps an Overweight rating on the stock.